Small Cap Stocks Worth Watching – December 31st

Intelligent Bio Solutions, Sidus Space, Spring Valley Acquisition, Inflection Point Acquisition, Direxion Daily TSLA Bear 1X Shares, Vanda Pharmaceuticals, and ESH Acquisition are the seven Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations—commonly defined as roughly $300 million to $2 billion—though exact cutoffs vary by index and region. They often offer higher growth potential but come with greater volatility, lower liquidity, and less analyst coverage, making them riskier and generally more suitable for investors with longer time horizons or higher risk tolerance. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.

Sidus Space (SIDU)

Sidus Space, Inc., a space-as-a-service company, engages in the design, manufacture, launch, and data collection of commercial satellite worldwide. Its space services include satellite/space hardware manufacturing; Low Earth Orbit (LEO) launch and deployment services; and space-based geospatial intel, imagery, and data analytics.

Spring Valley Acquisition (SV)

Inflection Point Acquisition (IPAX)

Direxion Daily TSLA Bear 1X Shares (TSLS)

The Direxion Daily TSLA Bear 1X Shares (TSLS) is an exchange-traded fund that is based on the Tesla, Inc. index. The fund provides inverse (-1x) exposure, less fees and expenses, to the daily price movement for shares of Tesla stock. TSLS was launched on Aug 9, 2022 and is managed by Direxion.

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company’s marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia.

ESH Acquisition (ESHA)

ESH Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets in the sports, hospitality, and music and entertainment sectors.